ACTRN12619000034134进行中（未招募）2 期
Melatonin for Delirium Reduction, Resolution And Mitigation of Abnormal Arousal (MelaDRRAMAA): a double blinded placebo-controlled randomised trial of Melatonin 5mg nightly for 5 nights for the reduction of severity of delirium in older adult medical inpatients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •Diagnosis of delirium (regardless of cause)
- •Inpatient of the Royal Melbourne Hospital
排除标准
- •- exclusively hypoactive delirium,
- •- recent stroke (<14 days),
- •- sensory impairment or dysphasia or language such that not evaluable,
- •- planned for surgery,
- •- prognosis <7days,
- •- severe hepatic failure
- •- allergy or intolerance to melatonin or excipients.
- •- Treated with Melatonin or melatonin agonists within 24 hours prior to enrolment
研究者
相似试验
招募中
3 期
The effect of melatonin in the treatment of delirium in critically ill patients admitted to the intensive care unitIRCT20141209020258N189Arak University of Medical Sciences80
尚未招募
不适用
Effectiveness Of Melatonin In Preventing Delirium In Critically Ill PatientsCTRI/2021/06/034425Dr Priyamvada Gupta
尚未招募
不适用
The effects of melatonin in the treatment of deliriumacute confusionpsychosis10012221NL-OMON32448Academisch Medisch Centrum702
进行中（未招募）
不适用
The effects of melatonin in the treatment of delirium - MAPLE BDelirium in elderly patients (65 yrs and older) acutely admitted to the ward of internal medicine.MedDRA version: 9.1Level: LLTClassification code 10012218Term: DeliriumEUCTR2008-006452-22-NLAcademic Medical Centre
尚未招募
不适用
The effects of melatonin in the treatment of delirium-a double blind, randomized, placebo-controlled trial.NL-OMON21861Academic Medical CenterAmsterdam200